CHINARES PHARMA (03320): Dong-E-E-Jiao's net profit attributable to shareholders for the first half of the year is 860 million yuan, an increase of 5.66% year-on-year.

17:23 20/08/2026

China Resources Pharmaceutical (03320) announced that its subsidiary, Dong'e Ejiao, achieved a total operating revenue of 3.155 billion yuan for the six months ended June 30, 2026, an increase of 3.39% year-on-year; net profit attributable to shareholders of the listed company was 860 million yuan, a year-on-year increase of 5.66%; basic earnings per share were 1.34 yuan.

CHINARES PHARMA (03320) announced that its subsidiary Dong-E-E-Jiao achieved a total operating revenue of 3.155 billion yuan for the six months ended June 30, 2026, representing a year-on-year increase of 3.39%; the net profit attributable to shareholders of the listed company was 860 million yuan, a year-on-year increase of 5.66%; earnings per share were 1.34 yuan.

POWER XINCHEN (01148) released its interim results, with a profit attributable to shareholders of 18.083 million yuan, an increase of 9.6% year-on-year.

NUOBIKAN (02635) announced its interim results, with profit attributable to owners of the parent company amounting to 53.688 million yuan, an increase of 33.95% year-on-year.

China Tourism Group Duty Free Corporation (01880) appointed Ye Wenhui as the co-secretary of the company, authorized representative, and legal process agent to replace Zhang Xiao.

POWER XINCHEN (01148) released its interim results, with a profit attributable to shareholders of 18.083 million yuan, an increase of 9.6% year-on-year.

NUOBIKAN (02635) announced its interim results, with profit attributable to owners of the parent company amounting to 53.688 million yuan, an increase of 33.95% year-on-year.

China Tourism Group Duty Free Corporation (01880) appointed Ye Wenhui as the co-secretary of the company, authorized representative, and legal process agent to replace Zhang Xiao.